Figure 6From: Down-regulation of human topoisomerase IIα expression correlates with relative amounts of specificity factors Sp1 and Sp3 bound at proximal and distal promoter regionsEndogenous topoisomerase IIα decreases concomitantly with decreased Sp1 and increased Sp3 after treatment with doxorubicin. (A) Topoisomerase IIα; (B) Sp1; (C) Sp3; (D) tubulin control, at time points 0 hours (i), 2 hours (ii), and 24 hours (iii) after exposure to doxorubicin in MDA MB 231 cells. The three proteins bracketed in C represent the isoforms of Sp3 produced from alternative start codons. Results show the average of three experiments carried out in triplicate and are expressed as ± SEM where n = 9, *** p < 0.001, ** p < 0.01, and * p < 0.05. The insert shows one indicative immunoblot.Back to article page